Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCB vs DES in Chronic Total Occlusion
NCT04744571Unknown
- Sponsor
- Beijing An Zhen Hospital
- Start
- Feb 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in chronic total occlusion of coronary artery (CTO), sponsored by Beijing An Zhen Hospital. Primary endpoint: Minimal Lumen Diameter at 12 months. Status: unknown.
02
Conditions
chronic total occlusion of coronary artery (CTO)
Beyond the preview
Go deeper on NCT04744571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04744571.